Trials / Recruiting
RecruitingNCT07093528
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
CMR Substudy of Coronary Sinus Reducer for the Management of Symptomatic Heart Failure With a Preserved Ejection Fraction (HFpEF) Associated With Coronary Microvascular Dysfunction (CMD)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Cardiovascular Magnetic Resonance (CMR) | Patients will consent to undergo a 50-minute non-invasive stress perfusion CMR. |
Timeline
- Start date
- 2025-10-16
- Primary completion
- 2027-08-01
- Completion
- 2027-08-01
- First posted
- 2025-07-30
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07093528. Inclusion in this directory is not an endorsement.